Phase II Clinical Trial of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 50 Years or Above

Clinical trial NCT07289542 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07289542
Sponsor: Suzhou Abogen Biosciences Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Respiratory Syncytial Virus

Start date: 2025-09-15
Primary completion: 2026-01-07
Enrollment: 420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.